Molecular characterization of respiratory syncytial viruses infecting children reported to have received palivizumab immunoprophylaxis

BACKGROUND: Respiratory syncytial virus (RSV) is a major cause of respiratory infections in children. Palivizumab (PZ) is the only RSV-specific immunoprophylaxis approved by the U.S. Food and Drug Administration. Mutations leading to amino acid substitutions in the PZ binding site of the RSV F prote...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Clin Virol
मुख्य लेखकों: Oliveira, Danielle B.L., Iwane, Marika K., Prill, Mila M., Weinberg, Geoffrey A., Williams, John V., Griffin, Marie R., Szilagyi, Peter G., Edwards, Kathryn M., Staat, Mary A., Hall, Caroline B., Durigon, Edison L., Erdman, Dean D.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Elsevier Science 2015
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7172275/
https://ncbi.nlm.nih.gov/pubmed/25766983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2015.01.016
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन